Search results for " threshold"

showing 10 items of 497 documents

Neuromuscular characteristics and fatigue in endurance and sprint athletes during a new anaerobic power test

1994

The purpose of this study was to investigate neuromuscular and energy performance characteristics of anaerobic power and capacity and the development of fatigue. Ten endurance and ten sprint athletes performed a new maximal anaerobic running power test (MARP), which consisted ofn x 20-s runs on a treadmill with 100-s recovery between the runs. Blood lactate concentration [la−]b was measured after each run to determine submaximal and maximal indices of anaerobic power (P 3mmol·1 −1,P5mmol·1 −1,P10mmol·1 −1andP max) which was expressed as the oxygen demand of the runs according to the American College of Sports Medicine equation: the oxygen uptake (ml·kg−1·min−1)=0.2·velocity (m·min−1) +0.9·s…

AdultMalemedicine.medical_specialtyAnaerobic ThresholdPhysiologyRunningAnimal sciencePhysiology (medical)medicineHumansOrthopedics and Sports MedicineAnaerobiosisLactic AcidTreadmillMuscle SkeletalMathematicsPhysical Education and TrainingbiologyElectromyographyAthletesPublic Health Environmental and Occupational HealthVO2 maxGeneral Medicinebiology.organism_classificationSprintPower testMuscle FatigueLactatesPhysical EndurancePhysical therapyProduction (computer science)Energy MetabolismAnaerobic exerciseEnergy (signal processing)European Journal of Applied Physiology and Occupational Physiology
researchProduct

Hybrid Functional Electrical Stimulation Exercise Training Alters the Relationship Between Spinal Cord Injury Level and Aerobic Capacity

2014

Objective To test the hypothesis that hybrid functional electrical stimulation (FES) row training would improve aerobic capacity but that it would remain strongly linked to level of spinal cord lesion because of limited maximal ventilation. Design Longitudinal before–after trial of 6 months of FES row training. Setting Exercise for persons with disabilities program in a hospitaL. Participants Volunteers (N=14; age range, 21–63y) with complete spinal cord injury (SCI) (T3-11) who are >2 years postinjury. Intervention Six months of FES row training preceded by a variable period of FES strength training. Main Outcome Measures Peak aerobic capacity and peak exercise ventilation before and after…

AdultMalemedicine.medical_specialtyAnaerobic ThresholdStrength trainingmedicine.medical_treatmenteducationElectric Stimulation TherapyPhysical Therapy Sports Therapy and RehabilitationThoracic VertebraeArticleYoung AdultPhysical medicine and rehabilitationHumansFunctional electrical stimulationMedicineLongitudinal StudiesExerciseSpinal cord injurySpinal Cord InjuriesAerobic capacityRehabilitationbusiness.industryRehabilitationMiddle Agedmedicine.diseaseCombined Modality TherapyExercise TherapyBreathingPatient ComplianceFemalePulmonary VentilationbusinessAnaerobic exerciseRespiratory minute volumePhysical Conditioning HumanArchives of Physical Medicine and Rehabilitation
researchProduct

Validity and Test-Retest Reliability of the TIVRE-Basket Test for the Determination of Aerobic Power in Elite Male Basketball Players

2016

The aims of this study were to (a) determine the relationship between performance on the court-based TIVRE-Basket test and peak aerobic power determined from a criterion laboratory-based incremental treadmill test and (b) to examine the test-retest reliability of the TIVRE-Basket test in elite male basketball players. To address aim 1, 36 elite male basketball players (age: 25.2 ± 4.7 years, weight: 94.1 ± 11.4 kg, height: 195.83 ± 9.6 cm) completed a graded treadmill exercise test and the TIVRE-Basket within 72 hours. The mean distance recorded during the TIVRE-Basket test was 4001.8 ± 176.4 m, and mean VO2 peak was 54.7 ± 2.8 ml · kg(-1) · min(-1), and the correlation between the 2 parame…

AdultMalemedicine.medical_specialtyBasketballAnaerobic ThresholdWheelchair basketballValidityPhysical Therapy Sports Therapy and RehabilitationBasketballAthletic Performance03 medical and health sciences0302 clinical medicineAge groupsLinear regressionmedicineHumansOrthopedics and Sports Medicine030212 general & internal medicineTreadmillReliability (statistics)Reproducibility of Results030229 sport sciencesGeneral MedicineQPTest (assessment)Exercise TestLinear ModelsPhysical therapyPsychologyJournal of Strength and Conditioning Research
researchProduct

Hypo-excitability of cortical areas in patients affected by Friedreich ataxia: A TMS study

2005

The aim of the study was to explore excitability of a motor and a non-motor (visual) area in patients affected by Friedreich ataxia and to correlate neurophysiological data with clinical parameters. Seven patients (3M/4F) and ten healthy controls (5M/5F) participated in the study. The hot-spot for activation of right abductor pollicis brevis was checked by means of a figure-of-eight coil and the motor threshold (MT) on this point was recorded. The phosphene threshold (PT) was measured by means of a focal coil over the occipital cortex as the lower intensity of magnetic stimulation able to induce the perception of phosphenes. The patients showed a significantly higher mean PT (p<.03) and MT …

AdultMalemedicine.medical_specialtyCerebellumAtaxiaAdolescentPhosphenesCentral nervous system diseaseMagneticsCortical excitability TMS Cerebellum Friedreich ataxia Visual cortex Motor cortex Hypo-excitabilityInternal medicineSensory thresholdCortex (anatomy)medicineHumansVisual CortexBrain MappingMotor Cortexmedicine.diseaseElectric StimulationSurgerymedicine.anatomical_structurePhospheneVisual cortexNeurologyFriedreich AtaxiaSensory ThresholdsCardiologyFemaleNeurology (clinical)medicine.symptomTrinucleotide Repeat ExpansionPsychologyMotor cortexJournal of the Neurological Sciences
researchProduct

Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: resu…

1999

Whether the safety and efficacy of implantable cardioverter defibrillator (ICD) therapy can be assured with lower output devices is an important question. The purpose of this study was to evaluate whether programming the device output at twice the augmented defibrillation threshold was as safe and effective as using the maximum energy. Patients indicated for ICD therapy, but without slow monomorphic ventricular tachycardia (MVT), who achieved an augmented defibrillation threshold (DFT plus)or = 15 joules (J) with a single endocardial lead system and a biphasic defibrillator were included in the study. Prior to ICD implantation, patients were randomized into 2 groups. The shock energies in t…

AdultMalemedicine.medical_specialtyDefibrillationTest groupmedicine.medical_treatmentImplantable defibrillatorDefibrillation thresholdElectrocardiographyLow energyInternal medicineMedicineHumansProspective StudiesAgedEjection fractionEquipment Safetybusiness.industryMiddle AgedImplantable cardioverter-defibrillatorDefibrillators ImplantableSurvival RateTreatment OutcomeShock (circulatory)Ventricular FibrillationCardiologyTachycardia VentricularFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessSoftwareThe American journal of cardiology
researchProduct

Predictive model to identify the risk of losing protective sensibility of the foot in patients with diabetes mellitus

2019

Diabetic neuropathy is defined as the presence of symptoms and signs of peripheral nerve dysfunction in diabetics. The aim of this study is to develop a predictive logistic model to identify the risk of losing protective sensitivity in the foot. This descriptive cross‐sectional study included 111 patients diagnosed with diabetes mellitus. Participants completed a questionnaire designed to evaluate neuropathic symptoms, and multivariate analysis was subsequently performed to identify an optimal predictive model. The explanatory capacity was evaluated by calculating the R (2) coefficient of Nagelkerke. Predictive capacity was evaluated by calculating sensitivity, specificity, and estimation o…

AdultMalemedicine.medical_specialtyDiabetic neuropathyMultivariate analysismellitus diabetesDermatologyLogistic regressionRisk AssessmentSeverity of Illness Index030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDiabetic NeuropathiesPeripheral nerveRisk FactorsInternal medicineDiabetes mellitusClinical Decision RulesmedicineHumansIn patient030212 general & internal medicineAgedAged 80 and overbusiness.industryOriginal ArticlesMiddle Agedmedicine.diseasepredictive modelsDiabetic footdiabetic neuropathyDiabetic FootCross-Sectional StudiesDiabetes Mellitus Type 1Logistic ModelsDiabetes Mellitus Type 2Sensory ThresholdsSurgeryFemalebusinessFoot (unit)diabetic foot
researchProduct

Increased amplitudes of distortion product otoacoustic emissions in patients with unilateral acoustic neuroma.

2004

We present a case series of 4 patients with a unilateral acoustic neuroma and increased amplitudes of the distortion products of otoacoustic emissions (DPOAEs) at the low- and middle- frequency bandwidth on the involved side compared to the uninvolved side despite a 28-dB hearing level (HL) worse (compared to the uninvolved side) pure-tone hearing threshold average for standard audiometric frequencies between 1 and 6 kHz at the involved side. In 3 of these patients, 2 with an inferior vestibular nerve origin of the acoustic neuroma and one in whom the nerve of origin could not be unequivocally defined, the tumor was extending extrameatally. One patient had a purely intrameatal acoustic neur…

AdultMalemedicine.medical_specialtyDistortion productOtoacoustic Emissions SpontaneousAcoustic neuromaAudiologyHearing Loss Unilateralotorhinolaryngologic diseasesmedicineHumansIn patientCochleaRetrospective StudiesAbsolute threshold of hearingbusiness.industryElectronystagmographyNeuroma AcousticMiddle AgedVestibular nervemedicine.diseaseMagnetic Resonance ImagingAmplitudeOtorhinolaryngologyHearing levelAudiometry Pure-ToneFemalesense organsbusinessORL; journal for oto-rhino-laryngology and its related specialties
researchProduct

Intratympanic gentamicin treatment after endolymphatic sac surgery.

2005

Interval treatment with up to three intratympanic gentamicin injections once weekly effectively controlled vertigo while preserving hearing in patients with Ménière's disease and recurrent or resistant vertigo after saccotomy.Recurrent or resistant incapacitating vertigo may occur after endolymphatic sac surgery (saccotomy) in patients with Ménière's disease. In these patients, revision saccotomy, vestibular nerve section or labyrinthectomy are the established treatment options. We advocate a once-weekly application of intratympanic gentamicin (12 mg) as an effective alternative in this group of patients.Five patients (age range 39-65 years) with definite Ménière's disease according to the …

AdultMalemedicine.medical_specialtyEar MiddleEndolymphatic sacInjectionsPostoperative ComplicationsRecurrenceVertigootorhinolaryngologic diseasesmedicineHumansEndolymphatic HydropsEndolymphatic hydropsMeniere DiseaseAntibacterial agentAgedbiologymedicine.diagnostic_testbusiness.industryAminoglycosideElectronystagmographyAuditory ThresholdGeneral MedicineMiddle Agedbiology.organism_classificationmedicine.diseaseSurgerymedicine.anatomical_structureOtorhinolaryngologyElectronystagmographyVertigoAudiometry Pure-ToneGentamicinFemaleEndolymphatic SacGentamicinsbusinessmedicine.drugMeniere's diseaseFollow-Up StudiesActa oto-laryngologica
researchProduct

Transient evoked otoacoustic emissions in vestibular neuritis.

2007

Objectives: Partial or total degeneration of the vestibulocochlear anastomosis at its takeoff from the saccular ganglion and regenerating efferent neural buds under the cochlear outer hair cells (OHCs) have been found in the temporal bones of human patients with a history of vestibular neuritis (VN). We sought to test whether VN has any functional impact on the ipsilateral OHCs by means of transient evoked otoacoustic emission (TEOAE) testing. Methods: We retrospectively analyzed prospectively collected TEOAE data of 28 patients (19 female, 9 male; age range, 21 to 60 years; median age, 42.5 years). The pure tone air conduction hearing thresholds at each standard audiometric frequency (0.12…

AdultMalemedicine.medical_specialtyEfferentNeuritisOtoacoustic Emissions SpontaneousOtoacoustic emissionAudiology03 medical and health sciences0302 clinical medicineotorhinolaryngologic diseasesMedicineHumans030223 otorhinolaryngologyVestibular NeuronitisSubclinical infectionRetrospective Studiesbusiness.industryPure toneAuditory ThresholdGeneral MedicineMiddle AgedVestibular nerveGanglionmedicine.anatomical_structureOtorhinolaryngology030220 oncology & carcinogenesisVestibular neuritisAudiometry Pure-ToneFemalesense organsbusinessBone ConductionThe Annals of otology, rhinology, and laryngology
researchProduct

A multiple biomarker risk score for guiding clinical decisions using a decision curve approach.

2011

Aims: We assessed whether a cardiovascular risk model based on classic risk factors (e.g. cholesterol, blood pressure) could refine disease prediction if it included novel biomarkers (C-reactive protein, N-terminal pro-B-type natriuretic peptide, troponin I) using a decision curve approach which can incorporate clinical consequences. Methods and results: We evaluated whether a model including biomarkers and classic risk factors could improve prediction of 10 year risk of cardiovascular disease (CVD; chronic heart disease and ischaemic stroke) against a classic risk factor model using a decision curve approach in two prospective MORGAM cohorts. This included 7739 men and women with 457 CVD …

AdultMalemedicine.medical_specialtyEpidemiologymedicine.drug_classBlood PressureDiseaseRisk AssessmentDecision Support TechniquesSex FactorsPredictive Value of TestsRisk FactorsInternal medicineTroponin INatriuretic Peptide BrainmedicineNatriuretic peptideHumansRisk thresholdProspective StudiesFramingham Risk Scorebusiness.industryTroponin IAge FactorsMiddle AgedPrognosisPeptide FragmentsSurgeryEuropeBlood pressureC-Reactive ProteinCholesterolCardiovascular DiseasesCohortBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersEuropean journal of preventive cardiology
researchProduct